Immune complex processing in C1q-deficient mice

Clinical and Experimental Immunology

Volumn 123, Issue 2, 2001, Pages 196-202

  Nash, J T ^a   Taylor, P R ^a   Botto, M ^a   Norsworthy, P J ^a   Davies, K A ^a   Walport, M J ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Complement mice deficiency monocytes; Macrophages immune complexes

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C1Q; FC RECEPTOR; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN FC FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; HYPOCOMPLEMENTEMIA; IMMUNE DEFICIENCY; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; COMPLEMENT C1Q; GENE DELETION; GENE EXPRESSION REGULATION; HUMANS; LUPUS; MICE;

EID: 0035119132     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01459.x     Document Type: Article

References (48)

1. Complement activation and complement receptors in systemic lupus erythematosus
2. Deficiency of the effector mechanisms of the immune response and autoimmunity
3. Quantitative chemical studies on complement or alexin I A method
4. Primate erythrocyte-immune complex-clearing mechanism
5. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor l-dependent mechanisms
6. 123I-labelled aggregates of IgG from the circulation
7. Immune complex processing in patients with systemic lupus erythematosis - In vivo imaging and clearance studies
8. Splenic uptake of immune complexes in man is complement dependent
9. Complement dependence of localisation of aggregated IgG in germinal centres
10. C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
11. Blockade of clearance of immune complexes by an anti-Fc gamma receptor monoclonal antibody
12. The in vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees
13. The blockade of Fc receptor-mediated clearance in vivo by a monoclonal antibody (2.4G2) directed against Fc receptors on murine leukocytes
14. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus
15. Defective Fc receptor mediated function of the mononuclear phagocyte system in lupus nephritis
16. A serial study of splenic reticuloendothelial system Fc receptor functional activity in systemic lupus erythematosus
17. Allelic polymorphisms of human Fcγ receptor IIA and Fcγ receptor IIIB. Independent mechanisms for differences in human phagocyte function
18. On the interaction of IgG subclasses with low-affinity FcγRIIa (CD32) on human monocytes, neutrophils, and platelets
19. Fcγ RIIa alleles are heritable risk factors of lupus nephritis in African Americans
20. Skewed distribution of IgG Fcγ receptor IIa (CD32) is associated with renal disease in systemic lupus erythematosus patients
21. Overrepresentation of the Fcgamma receptor type IIA R131/R131 genotype in caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis
22. Fcγ receptor IIa polymorphism in caucasian patients with systemic lupus erythematosus. Association with clinical symptoms
23. A novel polymorphism of FcγRIII (CD16) alters receptor function and predisposes to autoimmune disease
24. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
25. 125I-containing acylating agent
26. Protein and cell membrane iodinations with a sparingly soluble chloramide, 1,3,4,6-tetrachloro-3a, 6a-diphrenylglycoluril
27. A simple numerical method for the construction of isokinetic sucrose density gradients, and their application to the characterisation of immunoglobulin complexes
28. A microassay for the determination of hemolytic complement activity in mouse serum
29. Tissue distribution of intravenously injected dinitrophenylated human serum albumin. Effect specific IgG IgA antibodies
30. Immune adherence and the processing of soluble complement-fixing antibody/DNA immune complexes in mice
31. Studies of reticuloendothelial function in the mouse with model immune complexes: II. Serum clearance, tissue uptake, and reticuloendothelial saturation in NZB/W mice
32. PH Plotz Studies of reticuloendothelial function in the mouse with model immune complexes I. Serum clearance and tissue uptake in normal C3H mice
33. Clearance of circulating DNA-anti-DNA immune complexes in mice
34. The specificity of uptake of model immune complexes and other protein aggregates by the murine reticuloendothelial system
35. Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the non human primate
36. Clearance and organ localisation of small DNA anti-DNA immune complexes in mice
37. Clearance kinetics and organ uptake of complement solubilised immune complexes in mice
38. Complement depletion accelerates the clearance of immune complexes from the circulation of primates
39. A targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in close proximity, factor B, C2 and D17H6S45
40. Saturation of the reticuloendothelial system with soluble immune complexes
41. Difference in clearance kinetics of particulate immune complexes and soluble aggregates of IgG in vivo
42. Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseases
43. Clearance and tissue uptake of immune complexes in complement depleted and control mice
44. Clearance pathways of soluble immune complexes in the pig. Insights into the adaptive nature of antigen clearance in humans
45. Pulmonary intravascular macrophages
46. In vivo and in vitro studies of the binding of antibody/ds DNA immune complexes to rabbit and guineapig platelets
47. Monoclonal antibodies to mouse complement receptor type 1 (CR1) their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative
48. Characterisation of C3-binding proteins on mouse neutrophils and platelets